文献速递肾小球疾病

镜下血尿与IgA肾病系膜增生、毛细血管内增生、新月体评分及肾脏结局的关联

The association of microhematuria with mesangial hypercellularity, endocapillary hypercellularity, crescent score and renal outcomes in immunoglobulin A nephropathy.
PubMed 文献 · Nephrol Dial Transplant · 2021-01-01

本回顾性研究纳入125例活检证实的IgA肾病患者,评估MEST-C评分成分与活检时镜下血尿的关联,以及随访期间血尿程度与eGFR变化的关系。基线有镜下血尿者更易出现M1、E1和C≥1病变;随访血尿程度加重独立预测eGFR下降,严重镜下血尿者下降更显著。

要点

  • 基线镜下血尿与M1、E1、C≥1病变相关(P<0.05)。
  • 随访血尿程度加重独立预测eGFR下降。
  • 严重镜下血尿(≥21 RBCs/hpf)与更大eGFR下降相关。

核心结论

  • 随访期间镜下血尿程度是调整临床和病理参数后eGFR下降的独立预测因子。
  • 评估IgA肾病患者时,监测镜下血尿程度与蛋白尿同样重要。

研究设计与样本

  • 回顾性研究,纳入125例活检证实的IgA肾病且活检时未用免疫抑制治疗的患者,均有MEST-C评分。
  • 镜下血尿定义为≥3 RBCs/hpf;125例中97例基线有镜下血尿,72例有随访数据。

主要发现

  • 基线有镜下血尿者更易出现M1、E1和C≥1病变(P均<0.05)。
  • 随访血尿程度增加与eGFR下降-0.81 mL/min/1.73 m2相关(95%CI -1.44至-0.19,P=0.01),已调整随访时间、蛋白尿和T评分。
  • 严重镜下血尿(≥21 RBCs/hpf)与eGFR下降-3.99 mL/min/1.73 m2相关(95%CI -6.9411至-1.0552,P=0.008),调整因素同上。

临床怎么用

  • 在IgA肾病随访中,除蛋白尿外应监测镜下血尿程度以评估肾脏结局风险。

局限性

  • 回顾性研究设计。
  • 仅72例有随访数据。
  • 需以镜下血尿改善为主要替代结局的进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Microhematuria is common in immunoglobulin A nephropathy (IgAN). However, current prognostication is based on proteinuria and mesangial hypercellularity, endocapillary hypercellularity, segmental sclerosis, tubulointerstitial fibrosis and crescent (MEST-C) scores. METHODS: In this retrospective study, we evaluated whether MEST-C score components are associated with the presence of microhematuria at biopsy and whether the degree of microhematuria during follow-up is associated with change in estimated glomerular filtration rate (eGFR), after adjusting for clinical and histological parameters. We identified 125 patients with biopsy-proven IgAN and MEST-C scoring who were not on immunosuppressive therapy at biopsy. Microhematuria was defined as ≥3 red blood cells (RBCs)/high-power field (hpf). RESULTS: Of the 125 patients, 97 had microhematuria at baseline and were more likely to have M1, E1 and C ≥ 1 lesions (P < 0.05 for all) compared with patients without microhematuria. Of the 125 patients, 72 had follow-up data available. An increase in the degree of microhematuria was significantly associated with an eGFR decline of -0.81 mL/min/1.73 m2 [95% confidence interval (CI) -1.44 to -0.19, P = 0.01], after adjusting for follow-up time, proteinuria and T score. Severe microhematuria (≥21 RBCs/hpf) was associated with an even larger decline in eGFR (-3.99 mL/min/1.73 m2; 95% CI -6.9411 to -1.0552, P = 0.008), after similar adjustments. CONCLUSION: Degree of microhematuria during follow-up is an independent predictor of eGFR decline after adjusting for clinical and histological parameters. Therefore, monitoring the degree of microhematuria as well as proteinuria is important when evaluating patients with IgAN. Additional studies using improvement in microhematuria as a primary surrogate outcome are needed.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Bobart SA, Alexander MP, Shawwa K, et al. The association of microhematuria with mesangial hypercellularity, endocapillary hypercellularity, crescent score and renal outcomes in immunoglobulin A nephropathy. Nephrol Dial Transplant. 2021. PMID: 31859353. doi:10.1093/ndt/gfz267

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。